Capillary Forces and Bone Regeneration
Sep 5, 2023
Sept. 13, 2012. BioEngineering Seminar Series. University of Illinois Urbana-Champaign
"Capillary Forces in Cap Scaffolds and Their Role in Bone Regeneration"
Amy J. Wagoner Johnson, Associate Professor, Mechanical Science & Engineering and Affiliate Faculty Member of Bioengineering, UIUC
All right, so we're going to get it started.
And today we are very fortunate to have Professor Amy Wagner
from Mechanical Engineering and Science
to give us an exciting talk.
So Dr. Wagner graduated from Ohio State
with a bachelor's degree
and pursued a graduate study at Brown University
and got a degree in Mechanics and Materials.
And now her work is really at the interface,
a cutting-edge interface,
between biology, materials, and mechanics, right?
And this will be also applied to regenerative medicine.
We look forward to your talk.
Thank you.
Okay, so as Peter said,
I went to Brown University for graduate school.
I studied metal-makings composites
for ballistic applications.
So now I'm on the other side of that
and trying to repair the bone
and not protect the tank from explosions.
So I'm going to talk about capillary forces
and their role in bone regeneration today
in the context of calcium phosphate scaffolds.
And this is...
I haven't presented some of this anywhere at all, ever.
So call me stupid, call me brave, I don't know.
Call me what you want, but just a little warning.
So I do want to acknowledge some of my students.
So Sheeney graduated a couple years ago,
and she did some of the work
that's at the beginning of the talk
that I'm using to kind of build up the newer stuff.
Dave graduated last fall,
and his work was on the manufacturing side.
So his work is really going to enable
some of the next work that we're going to do
where we can really explore these capillary forces more.
And then Sam, Sam's kind of the star of the presentation here.
She's a bioengineering student.
She's not here, so I can talk about her.
And she's an MD-PhD student.
She just started M2,
and I just heard that she just submitted her thesis
to our committee today.
So that's kind of exciting.
And a lot of other students contributed to this, of course.
My group really works as a team, especially on this project.
And so I'm, and I also just want to acknowledge my colleagues.
Andrew O'Lean worked with me on manufacturing,
and Matt Mueller and Sherry Clark
helped with the initial Indivo studies
that I'm going to show you.
So probably most of you,
if you've been to any kind of tissue engineering talk
or bone tissue engineering talk,
you've seen slides like these.
So the current practice in bone-deep graft repair
is allograft and autograft.
Both have disadvantages, or else I wouldn't be doing this.
So the autograft is when usually you take bone
from your iliac crest.
And both allograft and autograft have limited supply,
so allograft is from a donor.
These are some of the complications
associated with autograft.
And the allograft, one disadvantage
is that there's disease transmission
or risk for disease transmission.
And if you sterilize the bone to decrease that risk,
then you change the properties,
and it's not as good, it's not as effective.
So the ultimate goal is to be able to take
a patient's CT scan like the one I've shown you there.
And you can see this woman has about four teeth,
so then her bone has resorbed in her jaw.
And the idea is to custom design a scaffold
that will fit into that defect for that particular individual.
And I'm not working on the customization part,
taking the images.
I'm working at a little bit different length scale,
which I'll talk about in a minute.
The material system is biphasic calcium phosphate.
It's just a calcium phosphate material.
I usually just say hydroxyapatite because it's easier.
There's not a lot of difference.
The composition is a little bit different.
The reason this is a good material to use
is because it's similar to the mineral that's in your bone.
It's bioactive, and that means that it will actually bond
or form a chemical bond with the bone.
It's osteoconductive, meaning that bone will grow on it.
And in some cases, it's osteoinductive,
which means that it will actually cause stem cells
to differentiate and form bone.
The other three things that I've listed here
are also reasons we use it,
but they're kind of more specific to what I'm talking about.
One is that it has an affinity for growth factors like BMP2.
So BMP2 is a bone morphogenic protein that is osteoinductive,
and it has binding sites that allow it to bind to hydroxyapatite.
The next one is that we can tailor the microstructure.
And the fabrication method that we use
allows us to tailor it more than some other folks
who use this material.
And then the last bullet point is related to Dave's work,
and that is that we can fabricate complex parts.
So what he developed
was a way to make scaffolds that have multiple materials.
So for this particular fabrication method, that wasn't possible.
But what that allows us to do is to make overhanging structures.
This is just kind of a cute example.
But it also allows us to have two different materials in here.
So this material is more dense than this material,
and this little sphere has a hole in the middle.
And he got a journal cover in the fall
that just showed up in the mail,
and they didn't tell us or anything,
but we were pretty excited about it.
Okay, so you can see what I refer to as macroscale porosity.
So all of these, you can see macro porosity.
It's on the order of a couple hundred microns,
and it's critical because if you don't have that,
the bone has nowhere to grow in.
But it's also important for nutrient waste transport.
And so a lot of people have spent a lot of time
looking at architecture, pore size, pore fraction, pore shape,
all of these different factors.
And basically the main conclusion so far
that they've been able to make for sure,
which I now dispute,
is that the minimum pore size is 100 microns.
So you have to have pores that are 100 microns in size
in order for bone to grow into the pores.
And these are just some examples of scaffolds in the literature.
So what I'm actually interested in is at a smaller length scale,
and that's the micro porosity.
So when I refer to micro porosity,
I'm referring to the porosity of these rods
that make up the scaffold.
And so a lot of what I've done
is either have solid rods or micro porous rods.
And then just recently we've started to change
the characteristics of the pores within the rods
instead of just looking at solid and porous.
So this group, Habitavik, has done quite a bit of work
where they've looked at the effects of micro porosity
on bone and growth.
So the way that they make their micro porosity
is by changing the sintering temperature.
So this is a ceramic material, and it has to be sintered.
So you can see they've sintered at a lower temperature
and a higher temperature.
It results in different density of material.
But the pore size there is about 1 micron.
It's very strong.
And it's not very controllable.
What they showed is that when you have micro porosity,
the bone volume increases and the bone apposition,
so how much bone is in contact with the scaffold, increases.
And what they say is that this is kind of a busy picture,
but I'm going to use the pointer now.
So what they have said,
so I've covered up the macro structure.
We're not going to talk about that.
But they have looked at micro porosity,
and they've basically said that it boils down to surface area.
So this micro porosity gives you a lot of surface area,
and that surface area either is used
to precipitate biological appetite,
so the ions in the calcium phosphate kind of dissolve,
and they re-precipitate in a more biological form
of this material.
And then the other thing this surface area allows for
is the adsorption of these BMPs.
So I had said before that BMPs have an affinity
for this material.
So those are the main factors,
and then those lead to stem cell differentiation,
which leads to bone formation.
So that's their hypothesis.
And obviously, you can tell by the way I'm talking
that I don't agree, and I'll show you.
So this is something that relies on someone infusion
and it's time-dependent.
So it's not going to happen at the very beginning,
and it's difficult to capture that
because there's so much going on,
and you really have to do it in vivo.
So this is our scaffold system.
As I mentioned, we use a fabrication process
that we call directed deposition.
We take a toothpaste-like material,
and we put it in a syringe.
We extrude it out of a nozzle in a defined pattern,
like shown here.
And when we deposit it, it's really like toothpaste.
So then we center it.
And for most of the in vivo study stuff
that I'm going to show you,
then we machine it out of a block like this.
And these are kind of the length scales we're talking about,
so the rod size is about 400 microns,
and the core size is about 360.
We can vary that, but this is what we've done
for some of the in vivo studies.
Then again, if you zoom in to the rods,
you have microchorus and non-microchorus.
That's how I refer to it.
So for the in vivo studies that I'm going to talk about first,
these are some of the characteristics.
So first of all, how do we generate this microprocessing?
We use PMMA beads in this toothpaste,
and then they burn out when we center it at high temperature.
And so by controlling the bead size and fraction,
we can control the architecture
or the microarchitecture we want of this.
So we're generally working with micropore sizes
that are about 5 microns,
and then the interconnections between those are even smaller.
So this is some of our...
actually the first in vivo study that I did.
And what we did in this case is we took these scaffolds
and we implanted them into muscle.
And we were looking at what is the role
of microchorus versus non-microchorus.
And when you put things in muscle,
you don't generally form bone.
And so we had to add this BMP2
in order to see if we could form bone at all.
And this is sort of the cheap way to do an in vivo study
is to put these things in muscle.
So we added this BMP2,
but we added it to gelatin microspheres,
and then we suspended the gelatin microspheres
in a very dilute gelatin solution,
and then we put it into the scaffolds.
So the idea there was to keep the BMP2
out of the microchorus and in the macrophorus,
but to still induce bone formation.
And so the result that we got was so striking,
there was no reason to even do any kind of statistical analysis at all,
because in one case we had bone, in the other case we didn't.
And that was consistent for every single sample that we looked at.
So this told us, well, we think microchorosity is doing something,
but since we put it in muscle,
we really have to do more work to figure out what's going on.
So then we implanted the cylindrical scaffolds in pig mantle,
and we just drilled holes in the ramus, which is right here.
So this pig is on his back, and you see this part here.
So we drilled the holes, put the samples in,
and left them in there for several different time points.
But in this case, so we looked at what happens if you include BMP,
what happens if you don't, what happens if you have microprocity,
and if you have no microprocity.
So those were the four conditions.
We looked at four time points,
and this meant that we had a ton of samples to analyze.
So one of the things that Sam did for her master's thesis
was she developed an algorithm that would allow us to use
microcomputed tomography to characterize the volume distribution
and specific surface area of the bone within the scaffolds very efficiently.
So a 900-image stack would take maybe an hour,
whereas before you could do a couple slices in an hour,
and we had over 100 samples.
So this was really a very useful algorithm that she developed,
and we're using it a lot.
So those are the groups.
I'm not going to go through all the results of that study
because I want to get to her other work,
but the basic or the most important results to this talk
were that the distribution of bone was very uniform.
So even at the earliest time point,
the distribution was almost completely uniform for the microporous samples.
So what this is showing is the bone fraction as a function of radius,
and we've normalized it.
And this blue line is the average.
So if you take the whole volume and average,
take the average amount of a volume fraction of bone,
that's what this blue line is.
And then this is the instantaneous.
So you can see that from the center of the scaffold out,
it just kind of jumps around the average,
and then it jumps up a little bit at the outside.
And so this is almost as uniform as you can get.
When we didn't have microporosity,
the middle of the scaffold had almost no bone at all,
and then it jumped up above the average on the outside.
So we had this ring of bone,
and this is a rendering of a CT image, and the blue is bone.
So you kind of see this ring of bone.
And that basically was the case for all time points for the non-microporous.
So that was one of the key results that we found.
And these are some histology images.
So first I want to just orient you,
and then I'll tell you the important result to take away.
This is the scaffolding cross-section,
and this kind of modeled stuff is the scaffold,
and the red is bone that's been stained.
And so you can look.
The bone is right up against the scaffold.
You can see this kind of penetrating composite interface
versus the case where you don't have any microporosity,
and you could imagine how that could be beneficial
for damaged mechanical properties, for example.
But the part that we found very interesting
was that this is a rod, this is a cross-section of a rod,
was that there was bone all through these pores,
and these blue things are cell nuclei.
And the reason that is quite interesting
is that if you remember I said that in the literature
basically every paper that talks about bone scaffolds
says that the minimum pore size is 100 microns,
and this clearly is happening in very, very small pores.
And so we had a hard time getting this past the reviewers
when we submitted this paper,
but now it's been out there for a couple years,
and the rest of the work we've done really further supports this.
So then I started showing this when I was giving talks,
and people would say,
how did the cells get in there?
And I was like, I don't know.
So one of the things that hopefully through the rest of the talk
that I want to impress upon you
is that we have actually figured out how and why those go in there,
and we think that the fact that they're in there
is why the bone growth is so much better.
And my experience with tissue regeneration studies
is that usually they can't figure out why.
They can't say it's better, and they don't know why,
and they can't explain why, and there are too many variables,
and so you kind of say, well, that's the way it is.
But we feel like we can do much better than that now.
So blue, nuclei cells in pores, and the red is bone.
So back to the question of how did they get in there.
We started designing migration experiments.
How can we sort of coax these cells in
and see if they actually can squeeze into these tiny pores
and migrate in and populate this structure?
And they just did not.
We got a project funded, but really we didn't really believe
that that was what was going on.
And so we decided to start thinking about something else.
So about a year ago, we started thinking about capillary forces.
And I'm not sure why this didn't occur to us earlier, but it didn't.
And so anyway, I'll talk about it now.
So the question is, can we use capillary forces
to pull the cells into this microstructure
and populate all of the micro pores?
If you remember, the interconnection size between the pores
is about 2 microns, and cells are generally 7, 10, some are bigger.
So that's kind of a lot of squeezing into a small space.
But this is a micropipette aspiration experiment,
so cells can deform quite a lot to get through there.
And so we thought, well, maybe this is a possibility.
So here's just the equation for the capillary force.
And then, I don't have the reference on it,
but Yang presented this critical pressure to get a cell into a pore.
So this is the cortical tension of the cell.
This is the radius of the pore, and this is the radius of the cell.
So then we started investigating that.
So I'm going to show you a simulation of the microstructure
and also some experimental results.
So Sam developed this kind of cute model
that turned out to work pretty well.
And so what we wanted to do was figure out
what are the capillary forces for this rod
if the cylinder is surrounded by fluid
and the fluid is going into the center of the rod.
So she took the pore size distribution that we had measured,
and she generated a volume where she just kind of plunked down
these little spheres that fit into that distribution.
And those spheres were the pores.
And then she took slices through that volume
to get an average of wetted perimeter,
which is shown here, this blue,
versus the area that you're looking at, area of the volume.
So then we could take into account,
so we're not looking at just a single capillary tube,
but we could take into account
that there's a different wetted perimeter
for these different microstructures.
So in doing that simulation,
oh, there's the answer,
she found that the capillary pressure was 584 pascals
for this particular microstructure.
So we wanted to be able to use that
to look at other microstructures,
and so we validated it.
So to do that, we looked at two different pore sizes,
2D substrates with different pore sizes,
and we just did simple capillary rise experiments.
So we measured the rise,
then we calculated the pressure generated,
and then we backed out the contact angle.
And we found that the contact angle was the same
as it should be, because that's a material property.
But then we also measured the contact angle
on a solid substrate surface,
and we found basically it's exactly the same.
And so that really validated the model
and suggested that we could use this model
for other microstructures as well.
And this was from the model.
This was from the experiments.
Okay, so now we've got a little model of the microstructure.
We can use that later.
We wanted to do some experiments
to try to isolate the capillary forces.
So if you remember, I put up that busy chart,
and people looked at grain size and surface roughness
and surface area and all these factors.
But we want to isolate the capillary forces,
and so to do that, we're still interested
in looking at these two microstructures
because they have different surface area,
but we also need to isolate the capillary forces.
So we did several conditions.
Of course, for the non-microporous,
there are no capillary forces because there are no pores.
But then we took the microporous one,
and we just filled the pores with fluid
so that we would get rid of the capillary forces.
So we would expect that this one is the one
that would have the high capillary forces,
and then experimentally,
we would see some differences in behavior
if we try to take advantage of those capillary forces.
So the first thing that we did,
we were actually trying to get the cells to go in,
but they just stuck on the surface,
and so then we were worried,
well, maybe it's just an adhesion thing
and not really a capillary force thing.
We weren't sure, but we saw a huge difference
in the microporous samples
compared to the ones without the capillary forces,
which basically were just the same,
and the cell density was really low.
So we pipetted the cell solution,
the cell suspension on,
waited, I don't remember how long we waited,
but 20 minutes, or I don't remember what it was,
and then rinsed them, and then this was the result.
And these cells are stained with cell tracker green.
So that was...
It showed that these capillary forces play a role,
and it's not like a surface roughness thing
because these two show the same behavior,
but it didn't show the cell penetration in the micropores.
And so we sort of had to think about that a little bit more,
and we looked back at this critical pressure,
and we wanted to look at different kinds of cells
because in vivo, there are all kinds of cells in that area
when you create the defect,
and so we wanted to see can some go in and some not
because we could also use that
as a design parameter in our samples.
So we looked in the literature
and got some values for cortical tension
and some cell radii,
and then we calculated the critical pressure,
and based on the experiment and simulation,
which is pretty much exactly the same,
we found that all of these cells,
except for the chondrocytes,
would be able to get into these pores,
into this porous microstructure.
So that was encouraging.
So then we decided to go back to some in vitro studies,
but we designed the experiments a little bit differently,
so that we have a little bit more control
over where the fluid was going
when we put it in contact with the sample
instead of just pipetting it on top.
So we took a glass substrate
and put a bead of the cell suspension on the substrate,
and then we just brought them close together,
and the thickness of the two was about the same.
And so that we brought it in contact evenly,
then we have this...
the cell suspension would wick into the substrate evenly.
And so that's what we did.
And we did that with several different cell types
that were, again, seen with cell tracker green.
And we found that these cells,
the different cell types,
actually did penetrate different distances.
And that this E1 type, which is a cell line,
but it's osteoblast-like cell line,
went the furthest,
and these other two were statistically similar.
So that was pretty exciting,
because it was the first very direct evidence that we had
that we could actually get these cells
to go in the pores through capillary forces.
And actually, also, I just will point out
that all of these distances are on the order of the rod size.
So the rod size, the diameter is 400 microns,
and so these would go pretty deep into the rod.
So then when we looked at those distances,
it was consistent with the critical pressure
that we calculated
based on information we had in the literature, basically.
So when we had low critical pressure,
they went farther for the low critical pressure.
And this one, we couldn't calculate at critical pressure
because we didn't have this information.
But that was consistent with the measurement.
So then we had an opportunity to put these in the animal again,
which doesn't...
it takes a lot of planning and time to get that to happen.
And this was actually done at Wash U Medical School,
not here on campus.
So we went there,
and we tried to do these similar experiments
where we put some samples in where they're soaked in PBS.
And actually, we don't just soak them.
We tap them and watch all the bubbles come out
so we know that all the pores are filled.
And so we created the defect,
and we put some in dry and some in that were filled in PBS,
and we looked at this as a function of time.
And the bottom line is that when the pores are filled,
you don't see cells penetrating at all,
which we expected but we wanted to show.
There is a little bit right here,
and we think that that could have been a bubble or something
where there was still air.
But you can see that these cells
have populated this particular rod almost uniformly.
If you look at it in cross-section,
you can see there's a kind of halo
where they may have stopped.
And here's a better picture
where you can really see how far they've gone.
So this is about 400 microns.
And so it varies a bit,
but it's around 100 microns when we did the measurement.
So now we have this evidence that even in vivo,
so not in a very controlled environment
where we're basically giving the fluid no choice
but to go directly in there.
In this in vivo environment, we can get the cells to go in.
But one thing that we had to be really careful of
is that we had to make sure that when we drilled the defect hole
that it actually filled with blood
and whatever else is ground up there when we make the defect,
because otherwise, obviously, this wouldn't work.
So what we showed in previous work
is that this microprocity enhances bone regeneration.
And we saw that these cells went into the pores,
and we think that that must be related
to this macro-scale enhanced regeneration that we observed.
And so then we were trying to answer this question,
how do the cells get in?
So what we have shown so far
is that with this one microstructure that we've looked at,
we can get both cell localization,
and the reason I'm emphasizing that
is that other people saw enhanced regeneration
with micropore structures,
but they didn't get cells in because the pores were too small.
So we think that the explanation for that
could be that they still have capillary forces,
and those capillary forces are drawing the cells
to the surface of the scaffold,
and they're not relying on cells to migrate into the scaffold
or to come in through vessels growing into the structure.
So we think that this offers an explanation
for other people's work as well.
But we also showed that these capillary forces
actually draw the cells in,
and we think they track them.
We haven't done experiments to see if they migrate out,
but I think it's pretty certain that they're trapped.
And then the penetration depth depends on the cell type,
and this is really interesting
because we might be able to design a microstructure
to select certain cells
or to select certain cells for certain regions in the scaffold,
and so that could be interesting by itself.
It's another sort of level of design.
So this part is more recent, very recent actually,
and the next thing that we wanted to do is,
if we change the microstructure,
how does that influence the results that we've seen so far?
And so, again, we changed the microstructure
by using different PMMA beads
and different volume fractions of those beads,
and all of this is with 2D substrates.
So we did a series of capillary rise tests
with two pore sizes, 5 and 50 microns,
and several volume fractions.
So we have to stay around 50%
because if we get to higher porosity than that,
then it just falls apart,
and the manufacturing won't work.
So then we sort of concentrated on a few
instead of doing these experiments with all of them,
but we looked at two pore sizes,
changed the volume fraction a little bit,
and then we looked at the larger pore size.
And we did the experiments again,
and we found that with a small pore size in this range,
volume fraction really doesn't do much at all.
But the capillary pressure is a lot lower
for the larger pores, which we would expect.
When we did the microstructure simulation, though,
we found, again, that it's very consistent
with experimental results, but for the 5-micron pores.
So it turns out that for these 50-micron pores,
it's really actually not very good.
And so we wanted to try to understand
why this model wasn't predicting this.
And so we started thinking about the geometry of the system
to try to explain this.
So this is a little simple geometric model
where these circles are the PMMA beads that are in the ink.
And then as these are distributed,
we are assuming that they're in contact,
but the volume fraction is such
that they're probably not all in contact.
But at least some of them are, so this is a good approximation.
And then the HA particles are kind of irregular,
so they might have some piece that sticks in in between.
And if that's wedged in there,
that's going to create the interconnection
between these PMMA beads.
So when we did that,
we calculated the interconnection size
for these two bead sizes.
And as you might expect, for the 5-micron,
and I forgot to put the numbers up,
but for the 5-micron pore size,
the interconnections were pretty similar
to the size of the pores themselves.
And for the large pores, the 50-micron pores,
the interconnections were much smaller than that pore size.
And again, this simulation doesn't match.
Well, the reason that the simulation doesn't match
is because it does not take into account
that these interconnections can form.
So really, we need to go back to the simulation
in order to really apply this
and use it for designing the microstructures.
We need to go back to the simulation
and figure out how to account for those interconnections
and try to get them incorporated into the model.
Okay, so we also, based on the interconnection size,
we said, well, what's the pressure generated
by having that size of a pore within the microstructure?
And then we said, what is the critical pressure
to get a cell to pass through those pores?
Because they have to pass through those pores
to make their way through the microstructure.
And we found that the critical pressure was high.
So we looked at this for osteoblasts,
and it would work.
The cells could pass through those interconnections.
This is changing a little bit,
but we also were looking at capillary rise
for fluorescent beads.
So when I showed the different cells
going into the microstructure,
we also did that with some beads,
but I didn't show that data here.
The reason that we're interested in looking at beads
is because they can be used as carriers for drugs,
and so we wanted to know how they might pass
through this microporous network
to potentially be used as drug carriers.
And we looked at the microstructure again,
and again, for these beads,
these two are the same,
and the 50%, 50 micron one is different.
So we sort of expected that,
but I thought I'd show the results.
We also did an acid etch to this,
and when we did the acid etch,
we did some, we looked at the microstructure,
and the more exposed grains were etched more.
And the more exposed grains are not the ones
that are butted up against the core,
because those are all nice and sort of tight
against the PMMA sphere before it burns out,
but these are the ones that are jetting
into the interconnections.
And so this acid etch, what it did was
it kind of opened up the interconnections.
It didn't change the pore fraction,
pore size much, but it kind of changed
the interconnections.
And so we found that that influenced
the distance that the water would move through.
So now we're trying to think about
how we can play around with pore size
and interconnection size to better control
where and how much things are passing
through this microstructure.
And so related to that, we looked at
incorporating the drug.
So we actually, I'm not showing this data,
but we looked at how incorporation and release
is influenced by this microstructure.
And we used sort of a designer peptide,
and we found that basically similar results.
So the incorporation was the same
when you had these small pores
but changed the fraction,
but the release was very different
when you changed the pore size.
So what we think is going on,
this is, so we've shown that the cells
can populate this microporous network.
We haven't directly shown that that is
behind the enhanced bone regeneration,
but obviously we think that's what's going on.
So what we think is that this provides
a self-loading mechanism that populates
the micropores with cells and with other stuff
that's in the defect area.
So that could be BMPs, it could be other proteins.
If you wanted to add drugs,
then it could also populate the pores
with drugs that you add.
And what this does is it traps,
especially the cells, because the cells
would have a hard time deforming by themselves
to get out.
So it traps the cells,
and it also retains growth factors.
And again, in a different work
that I'm not presenting,
we show some release effects of those drugs.
But what this does is it essentially
seeds the structure.
So instead of bone growing from the outside in only,
now you've got a source for signals from cells
and a source for growth factors
that are really embedded in and trapped
in that microstructure
and are influencing bone regeneration.
So that's some sustained source.
If you remember that I showed this plot
of the bone fraction as a function of radial position,
and I said that it's sort of hanging out
around this average,
and it actually jumps up a bit on the outside.
So now what we think is happening
is we're populating the micropores,
and so things are growing from the inside out,
but also from the outside in.
And so that is helping with the bone distribution.
When you don't have this way of self-loading the scaffold,
then the bone just grows from the outside in
in the non-micropores.
So one of the things that we would like to do
is to try to model that
and see if we can model that growth pattern
and show differences in growth patterns.
So what are the implications of this,
and where is it going now?
So one implication is that we think that this is a way
to heal much larger defects
than have been possible with this material,
and we think that that is going to be a big jump
in what's possible to do right now.
Another thing that we think that this is going to help with
is that we think we can actually steer the bone growth.
So by that, I mean just as sort of an extreme example
or a toy example,
we could design a scaffold that has some path,
some random path of microporosity,
and we would expect that if our hypothesis is correct,
we would expect bone to grow along that path.
So that means that we can strategically place
microporous regions
and have sort of strategic seeded areas
within the microstructure, within the scaffold.
And that's possible.
We can do that because of Dave's work,
where he's been able to do overhanging structures.
He's been able to combine multiple materials
within a single scaffold.
So that's where his work kind of comes back into the picture.
And again, I didn't show it,
but this is a way that we can sustain delivery of drugs
that might further enhance bone regeneration.
And then finally, I haven't talked about this.
When I did the first study, I did look at mechanical properties,
but it turns out that when you take these out of the bone,
you kind of destroy them,
and so it's very difficult to measure the mechanical properties.
But you can hopefully believe me
that this would enhance the fracture toughness
by having this co-continuous composite
where you have a softer material in the macroporous
and in the microporous.
And so with that, I hope I've given you this kind of full story
where we're very excited to have sort of figured out
this mechanism that hasn't been shown before
for this material.
And instead of doing more design on macroporosity,
which everyone has done,
and it hasn't really gone anywhere,
so now we want to focus on the microporosity.
And we think that with these results that we've shown,
we really can add some design to it
rather than just having random pore structure
because you change the central temperature.
But we have a lot more control.
We can strategically design these scaffolds.
So with that, I'm happy to answer any questions,
and thank you for your attention.
Questions?
We wanted to do something that was just pretty different,
and we had those beads and the 5-micron beads,
and we had some in between,
but we wanted to try to see if we could see a big difference.
So we felt like if we did something
that was kind of just a step,
we just might not capture any differences.
And then we would miss something important
simply because we chose 10-micron beads
instead of 15-micron beads.
Amy, nice talk.
You showed what you call like a toy simulation,
a toy model where your student packed in a lot of spheres
to model this.
And I want to think of it simpler,
it's more abstract sort of things,
because it seems like in the design space
there should be some scaling insight here.
So does it simply scale with the perimeter that you have?
Would it perimeter linearly, for example?
Are there any simpler scaling relations
that you can take out of this?
I don't know.
So we have not looked into that.
But I think if you...
So I think these interconnections
because of the fluid flowing through
and this kind of constriction,
I think those interconnections are very important.
So that essentially gives you
kind of a bimodal distribution of pore size.
And so I don't know how that would influence
something like the scaling law.
Because it's true,
if you simply make the pores bigger
and nothing else changes,
you know, it's not really doing much.
But adding this interconnection part
kind of complicates things a bit more.
Sure.
Yeah, I guess I just wonder
if you can abstract everything
in terms of scaling with the total wetted perimeter,
which is how you would do it
in just a simple capillary rise with two, for example.
If that's the only...
You know, if you can simplify
to that low-dimensional idea,
then that would drive maybe some creative design
of just how to get more perimeter.
Yeah.
Well, I think that's true,
but that doesn't...
You still have to...
So if you're talking about just pulling in proteins
or beads that are much, much smaller
than the other features,
I think that's probably okay.
But with the cells,
you know, what is optimized for one cell type
might not work.
For example, the chondrocytes,
it wasn't going to work.
So I think it depends on...
It could depend on
whether you're talking about
deformable things that are moving through
or just fluid or fluid with proteins
or fluid with carriers.
And we just have not thought much beyond
what you see today.
Okay.
I have the opportunity to ask questions.
It's a wonderful talk, by the way.
So we are very interested in stem cells.
And recently, people were showing
the stem cell can feel the porosity
basically when the extracellular coating
is coated on the porosity materials.
And then the cell will feel that the cell
on the right from the empty space,
the anchoring point will relax
and feel it's more soft.
So have you been thinking about
utilizing these wonderful tools
to study polyamory stem cells?
We haven't thought much about this.
So this is, you know,
a lot of the cell-material interaction work
is with soft materials and fibers
and you can make all that.
And I don't know that that,
because you're trapping the cells
and they don't have a choice
and they can't get out,
I don't know that you can look at it
in the same way as, you know,
limiting the number of attachments
by the fiber density that you put in the cell.
It's kind of, so I think there's probably
some things that you could learn
from this related to that.
But I don't think you can directly apply it
because it's a hard material
and you're not getting any choices.
They have no choice once they're in there
is what I think.
I don't think they're going in there.
And I don't know for sure
because we haven't seen.
And I'm excited about, you know,
when I started doing NeuVivo stuff,
it's really good because, you know,
it's more realistic,
but it's so hard to get anything out.
So I'm so happy when Sam
started doing in vitro stuff
and we could control something.
So I bet there's a lot of interesting stuff.
Any questions?
You guys are showing concentration of cells
for porosity and micro porosity.
And micro porosity, right?
I don't think the same state,
drawn in the same state,
but it seems like the one with low porosity
and higher outside.
So the reason higher
than the one with micro porosity
on the outside.
Right.
So I guess I could look back.
I think they're at the same scale,
but my answer would be...
Yeah, they're the same scale.
So I think it's just a different mechanism
that's going on in there.
So I think in the one case
for the non-micro porous,
the only thing it's doing
is drawing from the outside in.
So it's possible that it is trying
to fully fill those macro porous,
but that's all it can do.
And in the other case,
it jumps up a bit.
Oh, actually, that's not right.
It is lower on the non-micro porous.
So this one jumps up a lot
because that's basically the only source
of where the bone is growing from.
This one here, the micro porous,
is at 0.6, so this one's 0.5.
So it is higher on the micro porous.
So it is probably added to it.
So it's growing from outside in,
and even on the edges,
it's growing because of the rods
being populated with cells
and proteins and things.
That's what we think is happening.
So we just dip the scaffold in PBS
and tap it to get all the bubbles out.
Then we put it in the cell culture dish
and pipette the cell suspension on top.
And in the other case,
we just have it dry.
We put it in the dish,
pipette the cell suspension on top,
and then after a few minutes,
then you fill it with the cell culture media.
Does that make sense?
Is that what you're asking?
So the question is,
does this kind of be counted?
No, it fills up
because it takes the cell suspension
and draws the cell suspension in.
And in the other case,
you've got it...
But what happens to micro porous?
Well, in one case,
we fill them with PBS
and then put the cell suspension on top.
And in that case,
they just hang out on top
if it's 2D substrate.
In the other case,
we put it in the dish dry,
and then we put the cell suspension on top.
And the sample sucks in
the cell suspension and the cells.
And the fluid goes much, much further
than the cells do.
But the cells go into the pores
and then kind of stop.
So it's happening in both cases.
It's just the second case,
the cells go in first.
Yes.
Right.
First case,
without the cell.
Well, because we fill it with PBS first.
Right?
They're all filled.
Yeah.
Well, that's...
We think it's a possibility.
I don't think that we are there
anywhere close right now.
But it might be possible, for example,
to design the rod
to have different,
like a graded porosity
so that certain cells get sucked to the center
and other cells stay to the outside,
even though you put the whole cell suspension in.
I think that that would be possible
just based on intuition, basically.
But we haven't done anything like that.
We've only done cell suspensions
with one single cell type.
And when we dip these in vivo,
we have no idea what cells are in those pores.
We know that there's a blue dot,
and that's all that we know.
And we've looked into trying to figure out
exactly what cells are in there,
but it's really, really difficult,
and we have not figured out how to do that yet.
So it could be, even in vivo,
there could be some region,
maybe the center that has one type of cell
and the outside that has another,
and we just can't tell based on the techniques
that we're using.
Sorry?
Oh, yes.
That sounds great.
Come talk.
I don't know if I want to do a startup,
but I think it could be interesting.
I think that there's a lot of different things
that you can do here.
I don't think it's just going to apply
to bone regeneration.
So whether I can pursue all of those things,
I think there's a lot of interesting stuff to be done,
and especially since we can now do fancy things
with the manufacturing technique.
Well, let's all speak again.
Thank you.
Applause

